ARTICLE | Company News
Neurogen, Sanofi-Aventis S.A. deal
September 20, 2004 7:00 AM UTC
The companies will terminate on Dec. 8, their 2001 deal to develop therapeutics against corticotrophin-releasing factor ( CRF1) for stress disorders, including depression and anxiety. The original de...